Reset
Showing 20 of 124 academic articles

A New Strategy for Efficient Screening and Identification of Monoclonal Antibodies against Oncogenic Avian Herpesvirus Utilizing CRISPR/Cas9-Based Gene-Editing Technology

Man Teng, Zi-Yu Zhou, Yongxiu Yao, Venugopal Nair et al. • Viruses (2022)

Marek’s disease virus (MDV) is an important oncogenic α-herpesvirus that induces Marek’s disease (MD), characterized by severe immunosuppression and rapid-onset T-cell lymphomas in its natural chicken hosts. Historically, MD is regarded as ...

DOAJ Open Access (DOAJ) DOI: 10.3390/v14092045

Encapsulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in liposomes prepared by thin film hydration and their transfer to mesenchymal stem cells and cord blood hematopoietic stem cells

Sławomir Lewicki, Monika Leśniak, Agnieszka Sobolewska-Ruta, Aneta Lewicka et al. • Archives of Medical Science (2020)

Introduction Cytokines are important immune modulator factors controlling homeostasis of the body and are involved in tissue regeneration after wound healing. The encapsulation of cytokines in liposomes has many advantages potentially usefu...

DOAJ Open Access (DOAJ) DOI: 10.5114/aoms.2020.94527

Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition

Susheel Kumar Nethi, Venugopal Gunda, Nagabhishek Sirpu Natesh, Brianna M. White et al. • iScience (2025)

Summary: Pancreatic cancer (PC) exhibits profound metabolic adaptations that support tumor progression, survival, and therapy resistance. Hypoxia-inducible factor-1α (HIF-1α) is a key regulator of these processes, promoting metabolic reprog...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.isci.2025.114088

Human RP105 monoclonal antibody enhances antigen-specific antibody production in unique culture conditions

Tatsuya Yamazaki, Kenta Iwasaki, Susumu Tomono, Masaki Imai et al. • iScience (2024)

Summary: Detecting antibodies, particularly those targeting donor human leukocyte antigens in organ transplantation and self-antigens in autoimmune diseases, is crucial for diagnosis and therapy. Radioprotective 105 (RP105), a Toll-like rec...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.isci.2024.110649

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target

Xiaofeng Duan, Stephen Iwanowycz, Soo Ngoi, Megan Hill et al. • Frontiers in Oncology (2021)

During tumor development and progression, intrinsic and extrinsic factors trigger endoplasmic reticulum (ER) stress and the unfolded protein response, resulting in the increased expression of molecular chaperones to cope with the stress and...

DOAJ Open Access (DOAJ) DOI: 10.3389/fonc.2021.629846

Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics

Ji Su Hwang, Seok Gi Kim, Tae Hwan Shin, Yong Eun Jang et al. • Pharmaceutics (2022)

Cancer is a group of diseases causing abnormal cell growth, altering the genome, and invading or spreading to other parts of the body. Among therapeutic peptide drugs, anticancer peptides (ACPs) have been considered to target and kill cance...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics14050997

Artificial intelligence in cancer target identification and drug discovery

Yujie You, Xin Lai, Yi Feng Pan, Huiru Zheng et al. • Signal Transduction and Targeted Therapy (2022)

Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems ...

OPENALEX cc-by DOI: https://doi.org/10.1038/s41392-022-00994-0 PMC: 9090746

Advances in ligand-targeted nanodelivery systems for leukemia therapy: from single- to dual-ligand strategies

Mingxin Hu, Chaoxing He, Jintao Hao, Nannan Qi et al. • Journal of Translational Medicine (2026)

Abstract Background Leukemia is a highly heterogeneous and aggressive hematological malignancy. Current therapeutic approaches (e.g. chemotherapy, radiotherapy, small-molecule targeted therapies, and hematopoietic stem cell transplantation,...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12967-026-07966-w

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report

Lars Kurch, Thomas W. Georgi, Astrid Monecke, Daniel Seehofer et al. • Frontiers in Oncology (2022)

A 28-year-old female patient with active and difficult-to-treat systemic lupus erythematosus (SLE) was diagnosed with liver-dominant diffused large B-cell lymphoma. Repeated response 18F-FDG-PET studies showed persistently high, and, despit...

DOAJ Open Access (DOAJ) DOI: 10.3389/fonc.2021.798757